General Pathology
Royal College of Physicians and Surgeons of Canada · 2.0 · 35 EPAs
Also available in French.
Every EPA in the published guide, shown as the form DebriefMD fills in, with its fields and answer options.
Transition to Discipline
TTD-1
Establishing skills in microscopy
Key features and assessment plan
- This EPA focuses on setting up and using a microscope to identify normal histology, peripheral blood smears and bone marrow (aspirate and trephine biopsy) and recognize adaptive processes such as metaplasia and hyperplasia. - This includes the use of Kohler illumination, a polarizing lens, and oil lenses, and performing basic microscope maintenance such as changing objectives and light bulbs. - This EPA includes reviewing cases using digital imaging software.
Direct or indirect observation by Core or TTP resident, or supervisor (e.g., slide exam, virtual microscopy) Use Form 1. Form collects information on: - Type of assessment: direct; indirect - Organ system or tissue (select all that apply): breast; bone & soft tissue; gynecology; gastrointestinal; genitourinary; head & neck; endocrine; skin; cardiovascular; thoracic; neuropathology; blood, bone marrow, lymph nodes & spleen; placenta Collect 13 observations of achievement - At least 1 of each organ system or tissue
Suggested observations: 13
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Type of assessment
- direct
- indirect
Organ system or tissue
- breast
- bone & soft tissue
- gynecology
- gastrointestinal
- genitourinary
- head & neck
- endocrine
- skin
- cardiovascular
- thoracic
- neuropathology
- blood, bone marrow, lymph nodes & spleen
- placenta
Medical Expert
- ME 3.4 Perform basic microscope maintenance
- ME 1.3 Apply knowledge of microscope use including Kohler illumination, polarization, and use of oil objectives
- ME 3.4 Use a light microscope to examine slides
- ME 1.3 Apply basic knowledge of normal gross and light microscopic appearance of tissues
- ME 1.3 Apply knowledge of the principles of digital photography
Collaborator
- COL 1.3 Discuss the roles and responsibilities of a general pathologist within the context of tumor board rounds
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTD-2
Participating in basic specimen handling
Key features and assessment plan
- This EPA focuses on applying the basic knowledge covered in the orientation to the laboratory in order to: match requisition and container and/or specimen; systematically verify the adequacy of patient and clinical information (requisition adequacy and completeness such as documentation of ischemic time) to initiate laboratory evaluation of a specimen; assess the appropriateness of selected simple surgical specimens for fixation (e.g., gallbladder, simple hysterectomy for fibroids, prolapse, colon for diverticulosis, ischemic small bowel etc.); select and recognize the appropriate fixative type/media/tube type, assess whether the quantity and size of the specimen container is appropriate, and address deficiencies as able; match slides, blocks, and requisition; assess blood specimens for hemolysis, icterus, lipemia, clotting, and adequate tube filling, and review and assess appropriate tube type; review a variety of microbiology specimens for adequacy and/or appropriate collection of media, and match requisition to specimen container. - The observation of this EPA is divided into two parts: specimen handling; and assessment of knowledge. - The assessment of knowledge will consist of a structured oral or written multiple- choice quiz, designed and administered by the supervising pathologist, on content related to the topic of specimen handling.
Part A: Specimen Handling Direct observation or case review by pathologist, TTP trainee, histotech, pathology or laboratory assistant, or laboratory technologist Use Form 1. Form collects info on: - Specimen type: tissue; blood; microbiological; appendix; gallbladder; simple hysterectomy for fibroids or prolapse; colon for diverticulosis; ischemic small bowel; other - Elaborate on specimen type (write in): - Fixative: fresh; formalin; alcohol Collect 15 observations of achievement - At least 3 different tissue specimens - At least 3 blood specimens - At least 3 microbiology specimens Part B: Assessment of knowledge Evidence of satisfactory completion of a structured oral or written quiz administered by the supervising pathologist Use Form 4 Collect 1 observation of achievement
Suggested observations: 15
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- Part A: ME 2.2 Identify basic principles of specimen adequacy
- Part A: ME 3.3 Recognize and discuss the importance of the triaging and timing of specimen collection
- Part A: ME 5.2 Apply safe practices in the laboratory, intraoperative consultation suite, and autopsy suite to minimize occupational risk
Collaborator
- Part A: COL 1.2 Discuss trouble-shooting issues with colleagues in the pathology department including MLAs/MLTs
- Part A: COL 1.2 Discuss the role and responsibilities of a specialist in General Pathology
- Part A: COL 1.2 Describe the roles and scopes of practice of other health care providers related to General Pathology
- Part A: COL 2.1 Respond to requests and feedback in a respectful and timely manner
Leader
- Part A: L 1.1 Apply knowledge of the principles of quality assurance pertinent to laboratory medicine
- Part A: L 1.4 Describe the data available from health information systems to optimize patient care
Professional
- Part A: P 1.1 Complete assigned responsibilities
- Part A: P 2.2 Demonstrate a commitment to patient safety and quality improvement through adherence to institutional policies and procedures
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTD-3
Summarizing and presenting relevant clinical information for clinicopathologic correlation
Key features and assessment plan
- This EPA focuses on extracting clinical information, including clinical history and relevant laboratory and imaging results from a number of different sources (including electronic), interpreting this information in light of the clinical question, and providing a summary. - This EPA may be observed in surgical pathology, cytopathology, autopsy pathology, or hematopathology. - At this stage, this does not include complex cases.
Case discussion and/or review of written clinical summary by pathologist or Core or TTP trainee Use Form 1. Form collects information on: - Lab discipline: surgical pathology; cytopathology; autopsy pathology; hematopathology Collect 2 observations of achievement
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Lab discipline
- surgical pathology
- cytopathology
- autopsy pathology
- hematopathology
Medical Expert
- ME 1.3 Apply knowledge of normal anatomy, physiology, and biochemistry
- ME 1.3 Apply knowledge of principles of cell biology, immunology, genetics, and pathogenic mechanisms, and the changes that occur in disease states
- ME 2.2 Gather a relevant clinical history
- ME 2.2 Interpret history and relevant investigations in light of the clinical question
- ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to supervisor
Communicator
- COM 2.3 Seek and integrate relevant information from other sources
Health Advocate
- HA 1.1 Analyze a given patient’s needs for health services or resources related to the scope of General Pathology
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTD-4
Creating a personal teaching and learning plan
Key features and assessment plan
- This EPA includes creating a logbook and portfolio that will be updated and maintained through all stages of training. - The specifics of the logbook will be determined by the individual resident and training program. Suggestions for the logbook include the following: date of activity, level of involvement with cases, type of case, diagnosis, discipline, and relevant guidelines/literature (if applicable). - The portfolio should include a narrative outlining the resident’s goals of training for the next period (duration of period and details of goals may be determined by the resident alone or in consultation with their mentor, senior resident, or program director). - The portfolio may include any additional activities that the resident has accomplished (i.e., workshops, conference attendance, continuing medical education activities, volunteer activity, etc.). - The logbook and portfolio are to be reviewed by the program director, academic advisor, mentor, and/or Competence Committee.
Resident’s submission of teaching and learning plan (portfolio), and logbook reviewed by pathologist, TTP trainee, academic advisor, or mentor Use Form 4 Collect 1 observation of achievement
Suggested observations: 1
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Leader
- L 4.1 Set priorities and manage time to integrate practice and personal life
Scholar
- S 1.1 Create a learning plan in collaboration with a designated supervisor identifying learning needs related to General Pathology
- S 1.1 Describe physicians’ obligations for lifelong learning and ongoing enhancement of competence
- S 1.1 Use technology to develop, record, monitor, revise, and report on learning in medicine
- S 1.1 Demonstrate a structured approach to monitoring progress of learning in the clinical setting
- S 3.1 Recognize uncertainty and knowledge gaps in clinical and other professional encounters relevant to General Pathology
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
Foundations
F-1
Assessing patients and integrating clinical and laboratory information in the evaluation of disease processes
Key features and assessment plan
- This EPA ensures the resident establishes the skills and knowledge of clinical medicine in order to effectively function, in later stages, as a pathology consultant for a wide variety of patients and conditions. - This EPA includes performing clinical assessments, including history and physical exam, selecting and interpreting the results of investigations, and collaborating with clinical colleagues to develop a differential diagnosis and treatment or management plan. - It also includes communicating with patients and their families to gather clinical information and convey information about the diagnosis and/or management plan. - This EPA will be observed in the ambulatory or inpatient setting, with adult and pediatric patients, in a range of medical and surgical clinical conditions.
Direct observation and/or case review by supervisor Use Form 1. Form collects information on: - Type of observation (select all that apply): direct observation of history; direct observation of communication with patients; case discussion or chart review - Setting: medicine; surgery; oncology; pediatrics; other Collect at least 10 observations of achievement - At least 2 of each type of observation - At least 2 each for medicine, surgery, oncology, and pediatrics - At least 1 assessment from a staff supervisor in each setting
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Type of observation
- direct observation of history
- direct observation of communication with patients
- case discussion or chart review
Setting
- medicine
- surgery
- oncology
- pediatrics
- other
Medical Expert
- ME 1.1 Demonstrate compassion for patients
- ME 2.2 Gather a relevant clinical history
- ME 2.2 Perform a physical exam that informs the diagnosis
- ME 2.2 Select and/or interpret investigations
- ME 2.2 Develop a differential diagnosis
- ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to supervisor
- ME 2.4 Identify and/or monitor key clinical features in the implementation of a management plan
Communicator
- COM 2.1 Use patient-centred interviewing skills
- COM 3.1 Convey information to the patient and/or family clearly and compassionately
- COM 3.1 Verify and validate the patient’s and/or family’s understanding of their care
- COM 4.1 Document the essential elements of a clinical encounter using a structured approach
Collaborator
- COL 1.2 Work effectively as a member of the clinical team
Professional
- P 1.1 Complete assigned responsibilities
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-2
Performing basic tasks in autopsy pathology
Key features and assessment plan
- This EPA focuses on the basic tasks of an autopsy including reviewing the consent form, reviewing and summarizing the chart, and performing limited basic procedures. - This includes: opening the pulmonary vasculature; opening the aorta, identifying and dissecting the main arterial branches of the aorta; opening the bowel; dissecting the pelvic block (bladder and reproductive organs); obtaining quality photographs as directed; completing required forms for ancillary tests (e.g., microbiology requisitions, biochemistry requisitions etc.). - This observation of this EPA is divided into two parts: verification of consent and chart review; performing basic tasks related to autopsy. - Performing a complete autopsy is a task of the Core stage.
Part A: Verification of consent and chart review Direct observation by pathologist or TTP trainee Use Form 1. Collect 2 observations of achievement Part B: Performing basic tasks related to autopsy Direct observation by pathologist or TTP trainee Use Form 2. Form tracks information on: - Task (select all that apply): open the pulmonary vasculature; open the aorta, identify and dissect the main arterial branches of the aorta; open the bowel; dissect the pelvic block; obtain quality photographs as directed; complete required forms for ancillary tests; other Collect 5 observations of achievement - At least three different tasks - No more than one ‘other task’
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- Part A: ME 1.6 Seek assistance in situations that are complex or new
- Part A: ME 2.1 Identify and explore clinical issues to be addressed in the pre-analytical, analytical and post-analytical handling of a case
- Part A: ME 2.2 Gather a relevant clinical history
- Part A: ME 3.2 Describe the provincial and institutional rules governing consent for autopsy
- Part A: ME 3.2 Identify the features of an appropriate autopsy consent
- Part A: ME 4.1 Recognize when a case requires involvement of the medical examiner
- Part A: ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to supervisor
- Part B: ME 5.2 Apply safe practices in the laboratory, intraoperative consultation suite, and autopsy suite to minimize occupational risk
- Part B: ME 1.3 Apply knowledge of normal anatomy, physiology, and biochemistry
- Part B: ME 1.3 Apply basic knowledge of normal gross and light microscopic appearance of tissues
- Part B: ME 1.3 Apply knowledge of the principles of embryologic development and common variations of normal development
- Part B: ME 2.1 Identify and explore clinical issues to be addressed in the pre-analytical, analytical and post-analytical handling of a case
- Part B: ME 2.2 Perform a pathological examination that is focused and relevant
- Part B: ME 3.4 Perform basic procedures in autopsy pathology
- Part B: ME 1.6 Seek assistance in situations that are complex or new
- Part B: ME 3.4 Photograph specimens
Collaborator
- Part A: COL 1.3 Communicate with clinical staff regarding issues of consent and clinical questions that need to be addressed
Scholar
- Part A: S 3.1 Generate focused questions that address practice uncertainty and knowledge gaps
- Part B: S 1.2 Seek and interpret multiple sources of performance data and feedback, with guidance, to continually improve performance
Professional
- Part A: P 3.1 Describe local regulations regarding the reporting of deaths to the medical examiner or coroner
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-3
Performing gross dissection of simple surgical specimens from accessioning to submission of blocks
Key features and assessment plan
- This EPA includes grossing select simple specimens, defined as non-malignant, single organ, routine indications and/or routine surgical specimens. - Examples include: simple hysterectomy for fibroids, skin ellipses, appendix, gallbladder, reduction mastectomy, colon for diverticulosis, and tissue biopsies. - This EPA also includes adherence to safety/quality assurance protocols, suggested time limits for grossing, appropriate number of sections to submit, and adherence to existing grossing protocols. - Indirect observation may involve the review of a ‘gross description’ by a supervisor after completion of grossing, including correlation with sections.
Direct or indirect observation by pathologist, pathology assistant, or Core or TTP trainee Use Form 2. Form collects information on: - Specimen type (write in): - Observation: direct; indirect Collect 10 observations of achievement - A variety of cases - At least 5 direct observations - At least 3 different observers
Suggested observations: 10
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 5.2 Ensure safe practices in the laboratory including applying universal precautionary measures, using PPE, and maintaining an organized workstation
- ME 1.3 Apply knowledge of normal anatomy and gross appearances of tissues
- ME 1.3 Apply knowledge of the principles of tissue fixation, decalcification, processing, and the potential impact of improper handling of fresh tissues
- ME 2.2 Gather a relevant clinical history
- ME 3.4 Perform appropriate dissection, description, and sampling of surgical specimens for routine and ancillary procedures
- ME 3.4 Photograph specimens
- ME 3.4 Work efficiently, ensuring appropriate fixation in a timely manner
- ME 3.4 Seek assistance as needed
Communicator
- COM 4.1 Document using standardized grossing templates and/or descriptions and protocols as much as possible
Leader
- L 4.1 Organize work using strategies that address strengths and identify areas to improve in personal effectiveness
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-4
Generating diagnostically accurate and complete pathology reports for simple surgical pathology cases
Key features and assessment plan
- This EPA focuses on providing an interpretation of simple surgical specimens, defined as non-malignant, single organ, routine indication, and/or routine surgical specimens - Examples include: simple hysterectomy for fibroids, skin ellipses, appendix, gallbladder, reduction mastectomy, colon for diverticulosis, and tissue biopsies. - This includes developing an approach to microscopic examination of a sample, arriving at the correct diagnosis, providing accurate descriptions, and formulating appropriate reports.
Direct observation by supervisor (General or Anatomical Pathologist, or Hematopathologist) Use Form 1. Form collects information on: - Organ system or tissue (select all that apply): breast; bone & soft tissue; gynecology; gastrointestinal; genitourinary; head & neck; endocrine; skin; lymph nodes; placenta - Number of reports reviewed (write in): Collect 10 observations of achievement - At least 4 different organ systems - At least 3 observers
Suggested observations: 10
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Organ system or tissue
- breast
- bone & soft tissue
- gynecology
- gastrointestinal
- genitourinary
- head & neck
- endocrine
- skin
- lymph nodes
- placenta
Medical Expert
- ME 1.3 Apply knowledge of the principles of tissue fixation, decalcification, processing, and the potential impact of improper handling of fresh tissues
- ME 1.3 Apply knowledge of routine histochemical staining
- ME 1.3 Apply basic knowledge of normal gross and light microscopic appearance of tissues
- ME 1.3 Apply knowledge of the principles of and indications for immunohistochemistry and special histochemical stains
- ME 2.2 Develop a differential diagnosis
- ME 2.2 Perform a pathological examination that is focused and relevant
- ME 2.2 Select and/or interpret investigations
- ME 2.2 Synthesize patient information to determine diagnosis
- ME 3.4 Seek assistance as needed
- ME 4.1 Ensure follow-up on results of ancillary tests, as relevant
Communicator
- COM 4.1 Document microscopic assessment accurately
- COM 4.1 Document information about patients and their pertinent medical history as it relates to the case
- COM 4.1 Generate a clear, concise report that enhances patient management
- COM 4.1 Identify and correct vague or ambiguous documentation
- COM 4.1 Integrate information from ancillary studies and other sources into the pathology report if applicable
- COM 4.1 Incorporate the data available from health information systems in the formation of a differential diagnosis and final report
Collaborator
- COL 1.3 Provide timely and necessary written information to colleagues to enable effective relationship-centered care
Leader
- L 2.2 Apply evidence and guidelines with respect to resource utilization in common clinical scenarios
Scholar
- S 1.2 Identify, record, prioritize and address learning needs that arise in daily work, using various strategies (e.g., scanning the literature, or attending formal or informal education sessions)
- S 3.1 Recognize uncertainty and knowledge gaps in clinical and other professional encounters relevant to General Pathology
Professional
- P 1.1 Complete assigned responsibilities
- P 2.2 Demonstrate a commitment to patient safety and quality improvement through adherence to institutional policies and procedures
- P 4.1 Demonstrate an ability to regulate attention, emotions, thoughts, and behaviours while maintaining capacity to perform professional tasks
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
Core
C-1
Selecting specimens for ancillary testing
Key features and assessment plan
- This EPA focuses on triaging specimens for ancillary studies based on the clinical scenario, and directing preservation and distribution of the tissue for further testing. - This includes handling specimens and submitting tissues for ancillary studies in the appropriate medium, including cytogenetics, molecular studies, in situ hybridization, immunofluorescence, lymphoma protocol, flow cytometry, electron microscopy, and reflexive/reflective lab testing following institutional SOPs. - This EPA includes the identification of sample deficiencies, including sources of pre- analytical errors. - This EPA will be observed at the time of specimen or result receipt. - At this stage, this EPA does not include ancillary test interpretation.
Direct observation or case discussion by pathologist, technologist or TTP trainee Use Form 1. Form collects information on: - Specimen type: tissue; blood; microbiological sample; other - Ancillary tests required or anticipated (select all that apply): immunohistochemistry; cytogenetics; molecular; in situ hybridization; immunofluorescence; flow cytometry; electron microscopy - Lymphoma protocol: yes; no Collect 6 observations of achievement - At least 2 other clinical laboratory specimens - At least 2 flow cytometry - At least 2 lymphoma protocol - At least 1 observation by pathologist
Suggested observations: 6
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Specimen type
- tissue
- blood
- microbiological sample
- other
Ancillary tests required or anticipated
- immunohistochemistry
- cytogenetics
- molecular
- in situ hybridization
- immunofluorescence
- flow cytometry
- electron microscopy
Lymphoma protocol
- yes
- no
Medical Expert
- ME 1.4 Recognize urgent problems that may need the involvement of more experienced colleagues and seek their assistance
- ME 1.6 Develop a plan that considers the current complexity, uncertainty, and ambiguity in a clinical situation
- ME 3.1 Recognize when a specimen might require ancillary studies
- ME 3.1 Describe the indications, contraindications, risks, and alternatives for a given test
- ME 2.2 Assess specimen adequacy for ancillary testing
- ME 3.3 Prioritize routine and ancillary studies when specimen adequacy is limited
- ME 3.4 Maintain the integrity required for the specific ancillary study (e.g., nucleic acid integrity for molecular testing, cell membrane for flow cytometry, viable cells for cytogenetics, etc.)
Collaborator
- COL 1.3 Consult with clinical colleagues, when appropriate, to ascertain if ancillary studies would be of value
- COL 1.1 Receive and appropriately respond to input from other health care professionals (e.g., pathology assistants, technologists)
Leader
- L 2.2 Apply evidence and guidelines with respect to resource utilization in common clinical scenarios
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-2
Performing medical autopsies and generating complete and diagnostically accurate reports
Key features and assessment plan
- This EPA focuses on medical autopsy, from receipt of the chart and consent form to the generation of an accurate, timely and clinically relevant final report. - This may include autopsies performed for natural deaths in a forensic centre. - This includes performing the external examination, organ evisceration, organ dissection, gross examination including diagnosing any pathology, drafting a preliminary report, ordering ancillary testing when necessary, examining the microscopic slides, and drafting the final opinion and report. - This also includes modifying standard autopsy procedures as necessary. - This EPA includes limited autopsies (examples: chest, heart, or brain only) and may include pediatric/fetal/perinatal cases. - The observation of this EPA is divided into three parts: initial assessment and preliminary report; organ evisceration; interpretation and final report
Part A: Initial assessment and preliminary report Direct observation by pathologist or TTP resident Use Form 1. Form tracks information on: - Case complexity: complex; routine - Case details: full; limited or focused autopsy - Pediatric/fetal/perinatal case: no; yes Collect 6 observations of achievement - At least 3 routine full autopsies - At least 3 complex full autopsies - No more than 2 pediatric/fetal/perinatal cases - At least 2 different pathologist observers Part B: Organ evisceration Direct observation by pathologist, TTP trainee, pathology assistant, or autopsy technician Use Form 2. Form collects information on” - Pediatric/fetal/perinatal case: no; yes Collect 1 observation of achievement - No more than 2 pediatric/fetal/perinatal cases Part C: Interpretation and final report Case review with pathologist Use Form 1. Form tracks information on: - Case complexity: complex; routine - Case details: full; limited or focused autopsy - Pediatric/fetal/perinatal case: no; yes Collect 6 observations of achievement - At least 3 routine full autopsies - At least 3 complex full autopsies - No more than 2 pediatric/fetal/perinatal cases - At least 2 different pathologist observers
Suggested observations: 6
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Pediatric/fetal/perinatal case
- no
- yes
Medical Expert
- Part A: ME 3.2 Ensure autopsy consent has been obtained and documented correctly
- Part A: ME 1.3 Apply knowledge of normal anatomy, physiology, and biochemistry
- Part A: ME 1.3 Apply knowledge of gross and microscopic appearances of tissues in disease states
- Part A: ME 1.3 Apply knowledge of the principles of and indications for ancillary diagnostic techniques
- Part A: ME 1.6 Seek assistance in situations that are complex or new
- Part A: ME 2.2 Gather a relevant clinical history
- Part A: ME 2.2 Perform a pathological examination that is focused and relevant
- Part A: ME 2.2 Select ancillary techniques judiciously in a resource-effective and ethical manner
- Part A: ME 3.4 Perform a complete autopsy, with appropriate full description and diagnosis at gross and microscopic levels
- Part A: ME 5.2 Apply safe practices in the laboratory, intraoperative consultation suite, and autopsy suite to minimize occupational risk
- Part A: ME 2.2 Interpret the findings of autopsy in the context of the relevant clinical history
- Part A: ME 3.4 Document procedures accurately
- Part B: ME 1.3 Apply knowledge of normal anatomy, physiology, and biochemistry
- Part B: ME 1.6 Seek assistance in situations that are complex or new
- Part B: ME 3.4 Perform organ evisceration
- Part B: ME 5.2 Apply safe practices in the laboratory, intraoperative consultation suite, and autopsy suite to minimize occupational risk
- Part C: ME 1.3 Apply knowledge of principles of cell biology, immunology, genetics, and pathogenic mechanisms, and the changes that occur in disease states
- Part C: ME 1.3 Apply knowledge of normal gross, light microscopic, and ultrastructural appearance of tissues
- Part C: ME 1.3 Apply knowledge of gross and microscopic appearances of tissues in disease states
- Part C: ME 2.1 Identify and explore clinical issues to be addressed in the pre-analytical, analytical and post-analytical handling of a case
- Part C: ME 2.2 Perform a gross and microscopic pathological examination that is focused and relevant
- Part C: ME 3.4 Utilize other areas of laboratory medicine, including microbiology, for diagnostic purposes
- Part C: ME 2.2 Interpret the findings of autopsy in the context of the relevant clinical history
- Part C: ME 4.1 Determine the need and timing of referral to another specialist and/or second opinion
Communicator
- Part A: COM 4.1 Prepare clear, concise, comprehensive, and timely written reports for autopsy consultations
- Part B: COM 3.2 Convey and document issues arising from a breach in quality or safety of laboratory practice
- Part C: COM 4.1 Prepare clear, concise, comprehensive, and timely written reports for autopsy consultations
- Part C: COM 4.1 Integrate information from ancillary studies and other sources into the pathology report
Collaborator
- Part A: COL 1.2 Work effectively with laboratory technologists and pathology assistants, directing their assistance
- Part B: COL 1.2 Work effectively with laboratory technologists and pathology assistants, directing their assistance
- Part C: COL 1.2 Consult as needed with other health care professionals, including other physicians
Leader
- Part B: L 1.2 Actively encourage all involved in health care, regardless of their role, to report and respond to unsafe situations
Scholar
- Part B: S 1.2 Seek and interpret multiple sources of performance data and feedback, with guidance, to continually improve performance
- Part C: S 3.1 Generate focused questions that address practice uncertainty and knowledge gaps
Professional
- Part C: P 3.1 Fulfil the requirements of the physician’s duty to report
- Part C: P 3.3 Prepare an autopsy for presentation at M&M rounds or departmental autopsy rounds
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-3
Performing routine forensic autopsies and generating complete and diagnostically accurate reports
Key features and assessment plan
- This EPA focuses on forensic autopsies in the adult and older child with manner of death including non-suspicious injuries, suicide, sudden natural deaths, intoxications, and complications of therapy. This EPA does not include homicide. - This EPA includes correctly performing the external and internal components of a forensic autopsy. This includes knowledge of injury documentation, description and interpretation, recognition of common forensic artifacts, correct sampling methods for forensic toxicology, and judicious sampling for microscopy. - This EPA also includes recognizing a case needing forensic autopsy, directing photography and/or taking photographs as appropriate, preparing a forensic autopsy report in the correct format, and certifying cause and manner of death in routine cases. - The observation of this EPA is divided into two parts: pre-autopsy assessment, dissections and examinations; interpretation and final report. - The observation of this EPA does not require that the resident has participated in both aspects of the case (i.e., resident can interpret and report cases for which they were not the original prosector).
Part A: Pre-autopsy assessment, dissections and examinations Direct observation by forensic pathologist, pathologist, or forensic pathology subspecialty trainee Use Form 1. Form collects information on: - Manner of death: natural; accidental; suicide; undetermined - Special dissections performed: yes; no - If “yes” specify dissection (write in): Collect 6 observations of achievement - At least 1 of each manner of death: natural, accidental, and suicide - At least 2 different observers Part B: Interpretation and final report Direct observation by forensic pathologist, pathologist, or forensic pathology subspecialty trainee Use Form 1. Form collects information on: - Manner of death: natural; accident; suicide; undetermined Collect 6 observations of achievement - At least 1 of each natural, accident, and suicide - At least 2 different observers
Suggested observations: 6
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Manner of death
- natural
- accidental
- suicide
- undetermined
Special dissections performed
- yes
- no
Medical Expert
- Part A: ME 3.2 Ensure autopsy consent has been obtained and documented correctly
- Part A: ME 2.2 Perform a pathological examination that is focused and relevant
- Part A: ME 2.2 Recognize common forensic artifacts
- Part A: ME 2.2 Select ancillary techniques judiciously in a resource-effective and ethical manner
- Part A: ME 3.4 Perform a complete forensic autopsy, including toxicological examination and the submission of specimens to the forensic sciences laboratory
- Part A: ME 1.3 Apply knowledge of gross and microscopic appearances of tissues in disease states
- Part A: ME 1.3 Apply knowledge of the principles of and indications for ancillary diagnostic techniques
- Part A: ME 1.6 Seek assistance in situations that are complex or new
- Part A: ME 2.1 Identify and explore clinical issues to be addressed in the pre-analytical, analytical and post-analytical handling of a case
- Part A: ME 2.2 Interpret the findings of autopsy in the context of the relevant clinical history
- Part B: ME 1.3 Apply knowledge of gross and microscopic appearances of tissues in disease states
- Part B: ME 2.1 Identify and explore clinical issues to be addressed in the pre-analytical, analytical and post-analytical handling of a case
- Part B: ME 2.2 Interpret the findings of autopsy in the context of the relevant clinical history
Communicator
- Part B: COM 4.1 Prepare clear, concise, comprehensive, and timely written reports for autopsy consultations
- Part B: COM 4.1 Integrate information from ancillary studies and other sources into the pathology report
Collaborator
- Part A: COL 1.2 Work effectively with laboratory technologists and pathology assistants, directing their assistance
Scholar
- Part A: S 3.1 Generate focused questions that address practice uncertainty and knowledge gaps
- Part B: S 3.1 Generate focused questions that address practice uncertainty and knowledge gaps
Professional
- Part A: P 3.1 Demonstrate understanding of the laws and policies relevant to conducting forensic investigations
- Part A: P 3.1 Adhere to requirements related to reportable diseases
- Part A: P 3.1 Describe local regulations regarding the reporting of deaths to the medical examiner or coroner
- Part B: P 2.1 Demonstrate a commitment to the promotion of the public good in health care, including stewardship of resources
- Part B: P 3.1 Demonstrate understanding of the laws and policies relevant to conducting forensic investigations
- Part B: P 3.1 Adhere to requirements related to reportable diseases
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-4
Performing gross dissection of surgical specimens
Key features and assessment plan
- This EPA includes all surgical specimens, both routine and complex. - Routine surgical specimens are defined as oncologic and non-oncologic, single-organ systems (may include lymph nodes) and may pertain to the following systems: breast; bone & soft tissue; cardiovascular; endocrine; gynecology; gastrointestinal; genitourinary; head & neck; lymph nodes or spleen; respiratory; skin. - Complex surgical specimens are defined as oncologic staging surgeries, single organ specimens of complex anatomy, multi organ specimens, specimens for non-routine indications (e.g., prophylactic specimens for BRCA) or other unique situations, including those requiring a contextual awareness of the case. These pertain to the following sites: breast; bone & soft tissue; cardiovascular; gynecology; gastrointestinal; genitourinary; head & neck; lymph nodes or spleen; neuropathology; placenta; respiratory; skin. - The observation of this EPA may be based on direct or indirect observation. - Direct observation is defined as the supervisor observing all or a component of the grossing of a surgical specimen; this may involve the discussion and elaboration of ‘an approach’ to the surgical specimen between the supervisor and resident, and review of surgical specimens at daily grossing rounds. - Indirect observation includes the review of a ‘gross description’ by a supervisor after completion of grossing, including correlation with gross photography, specimen mapping, and sections; second review of a surgical specimen with the resident following initial grossing (examples: additional sections); and/or discussion of specific protocols or approaches (e.g., CAP, oncologic) as they pertain to specific organ systems. - The observation of this EPA is divided into two parts: routine specimens; complex specimens.
Part A: Routine specimens Direct or indirect observation by staff pathologist, pathology assistant, subspecialty trainee or TTP trainee Use Form 2. Form collects information on: - Organ system or tissue: breast; bone & soft tissue; cardiovascular; endocrine; gynecology; gastrointestinal; genitourinary; head & neck; lymph nodes or spleen; respiratory; skin - Specimen type (write in): Collect 30 observations of achievement - A variety of organ systems - A variety of specimens - At least 5 each of breast, gynecology, gastrointestinal, and genitourinary - At least 10 different observers Part B: Complex specimens Direct or indirect observation by staff pathologist with feedback from pathology assistant, subspecialty trainee or TTP trainee Use Form 2. Form collects information on: - Type of observation: direct; indirect - Organ system or tissue: breast; bone & soft tissue; cardiovascular; gynecology; gastrointestinal; genitourinary; head & neck; neuropathology; respiratory; placenta; skin - Specimen type (write in): Collect 60 observations of achievement - A variety of systems - A variety of specimens - At least 12 gastrointestinal (including hepatobiliary/pancreas) - At least 8 each of gynecology, genitourinary, breast, and placenta - At least 5 each head and neck, and respiratory - At least 10 different observers
Suggested observations: 30
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Organ system or tissue
- breast
- bone & soft tissue
- cardiovascular
- endocrine
- gynecology
- gastrointestinal
- genitourinary
- head & neck
- lymph nodes or spleen
- respiratory
- skin
Medical Expert
- Part A: ME 1.3 Apply knowledge of normal gross examination
- Part A: ME 2.2 Perform a pathological examination that is focused and relevant
- Part A: ME 2.2 Review clinical history, imaging and other relevant data as necessary
- Part A: ME 3.4 Perform gross dissection, description, and sampling of surgical specimens, applying meticulous attention to block selection and mapping using diagrams and images and demonstrating awareness of downstream synoptic reporting and staging parameters, and the need to save tissue for research, tissue bank, and other indications, as necessary
- Part A: ME 5.2 Organize workstation to ensure safe practices in the laboratory
- Part A: ME 5.2 Adhere to universal precautions to minimize hazardous exposures including potential infectious and chemical agents
- Part A: ME 5.2 Use personal protective measures, including gowns, goggles, and slash resistant gloves
- Part A: ME 3.4 Work efficiently, ensuring appropriate fixation in a timely manner
- Part A: ME 3.4 Seek assistance as needed
- Part A: ME 3.4 Take high quality photographs of specimens
- Part A: ME 2.2 Formulate a differential diagnosis based on the pathological examination
- Part B: ME 1.3 Apply knowledge of normal gross examination
- Part B: ME 2.2 Perform a pathological examination that is focused and relevant
- Part B: ME 2.2 Review clinical history, imaging and other relevant data as necessary
- Part B: ME 3.4 Perform gross dissection, description, and sampling of surgical specimens, applying meticulous attention to block selection and mapping using diagrams and images and demonstrating awareness of downstream synoptic reporting and staging parameters, and the need to save tissue for research, tissue bank, and other indications as necessary
- Part B: ME 5.2 Apply safe practices in the laboratory, intraoperative consultation suite, and autopsy suite to minimize occupational risk
- Part B: ME 3.4 Seek assistance as needed
- Part B: ME 3.4 Take high quality photographs of specimens
- Part B: ME 2.2 Formulate a differential diagnosis based on the pathological examination
Communicator
- Part A: COM 4.1 Communicate findings in a timely fashion, with appropriate documentation
- Part B: COM 4.1 Communicate findings in a timely fashion, with appropriate documentation
Collaborator
- Part A: COL 2.1 Delegate tasks and responsibilities in an appropriate and respectful manner
- Part B: COL 2.1 Delegate tasks and responsibilities in an appropriate and respectful manner
Leader
- Part A: L 1.1 Participate in quality management, including appropriate use of standardized grossing templates and protocols, and use of judgment when submitting blocks regarding quality and quantity of sections
- Part B: L 1.1 Participate in quality management by minimizing cross contamination and using standardized grossing templates and protocols as appropriate
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-5
Diagnosing routine surgical pathology cases
Key features and assessment plan
- This EPA focuses on managing a routine surgical pathology case (e.g., a routine biopsy) from receipt of the hematoxylin and eosin (H&E) stained glass slides, to generation of a report that is ready to be verified by a staff pathologist. - This EPA includes matching the specimen with the requisition, ensuring that the correct patient material has been received with appropriate and accurate information, and that the processing has rendered the case satisfactory for interpretation (if not, pre-analytical issues that may have arisen should have been brought to the attention of the staff pathologist). - This EPA includes using the laboratory and hospital information systems to gather relevant history, and correlating relevant clinical history, gross description, medical imaging, laboratory tests, and previous pathology results - This EPA focuses on generating a differential diagnosis, selecting and interpreting ancillary studies (special/immuno stains, levels, etc.), incorporating results of ancillary studies when appropriate, utilizing synoptic templates when appropriate, appropriately using secondary review/subspecialty consultation, and preparing an accurate report ready for verification and review by staff pathologist. - Reviewing the case in a timely fashion, and organization and prioritization of work are additional features; this includes appropriate management of urgent cases, critical values, and reportable diseases. - This EPA may require communication with clinicians, or other house staff.
Direct and indirect observation with review of resident’s submission of report by pathologist or TTP trainee Use Form 1. Form collects information on: - Diagnosis (write in): - Organ system or tissue (select all that apply): breast; bone & soft tissue; cardiovascular; endocrine; gastrointestinal; genitourinary; gynecology; head & neck; lymph nodes/spleen; neuropathology; placenta; skin; thoracic - Pediatric: yes; no - Number of specimens reviewed (write in): Collect 70 observations of achievement encompassing a wide breadth of presentations - At least 7 from each of breast, gynecology, gastrointestinal, genitourinary, and skin - At least 3 from each of the other organ systems - At least 50 observed by pathologists - At least 10 different observers
Suggested observations: 70
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 1.3 Apply knowledge of gross and microscopic appearances of tissues in disease states
- ME 1.3 Apply knowledge of the principles of and indications for ancillary diagnostic techniques
- ME 2.2 Perform a gross and microscopic pathological examination that is focused and relevant
- ME 1.6 Seek assistance in situations that are complex or new
- ME 2.2 Gather a relevant clinical history
- ME 2.2 Formulate a differential diagnosis based on the pathological examination
- ME 2.2 Select ancillary techniques judiciously in a resource-effective and ethical manner
- ME 3.4 Use digital microscopy and interpret gross and microscopic digital images, including digitized and scanned slides
- ME 2.2 Establish a diagnosis that takes into account clinical correlations
- ME 4.1 Determine the need and timing of referral to another specialist and/or second opinion
- ME 1.4 Complete pathology reports within appropriate turnaround times
Communicator
- COM 4.1 Prepare clear, concise, comprehensive, and timely written reports for surgical pathology
- COM 4.1 Integrate information from ancillary studies and other sources into the pathology report
- COM 4.1 Use synoptic and other standardized reporting formats as appropriate
Collaborator
- COL 1.3 Convey information from the pathology assessment to clinicians in a manner that enhances patient management
- COL 2.1 Delegate tasks and responsibilities in an appropriate and respectful manner
Health Advocate
- HA 1.1 Respond to individual patient diagnostic needs and issues as part of patient care
Scholar
- S 3.1 Generate focused questions that address practice uncertainty and knowledge gaps
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-6
Diagnosing complex surgical pathology cases
Key features and assessment plan
- This EPA includes complex pathology reports defined as: oncologic staging surgeries; needle-core localization surgeries; single organ specimens of complex anatomy; specimens containing multiple organs; non-routine indications or findings. - This EPA includes matching the specimen with the requisition, ensuring that the correct patient material has been received with appropriate and accurate information, and that the processing has rendered the case satisfactory for interpretation (if not, pre-analytical issues that may have arisen should have been brought to the attention of the staff pathologist). - This EPA includes using the laboratory and hospital information systems to gather relevant history, and correlating relevant clinical history, gross description, medical imaging, laboratory tests, and previous pathology results - This EPA focuses on generating a differential diagnosis, triaging tissue for ancillary studies, selecting and interpreting ancillary studies, utilizing synoptic templates when appropriate, appropriately using secondary review/subspecialty consultation, and preparing an accurate report ready for verification and review by staff pathologist. - Reviewing the case in a timely fashion, and organization and prioritization of work are additional features; this includes appropriate management of urgent cases, critical values, and reportable diseases. - This EPA may require communication with clinicians, or other house staff.
Direct and indirect observation with review of resident’s submission of report by pathologist or TTP trainee Use Form 1. Form collects information on: - Diagnosis (write in): - Organ system or tissue: breast; bone & soft tissue; cardiovascular; endocrine; gastrointestinal; genitourinary; gynecology; head & neck; lymph nodes/spleen; neuropathology; placenta; skin; thoracic - Pediatric: yes; no Collect 70 observations of achievement encompassing a wide breadth of presentations - At least 7 from each gynecology, gastrointestinal, genitourinary, breast, and skin - A variety of specimens and diagnosis, including malignant and non-malignant, biopsies, and surgical resection - At least 10 observers
Suggested observations: 70
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 1.3 Apply knowledge of gross and microscopic appearances of tissues in disease states
- ME 1.3 Apply knowledge of the principles of and indications for ancillary diagnostic techniques
- ME 2.2 Perform a gross and microscopic pathological examination that is focused and relevant
- ME 1.6 Seek assistance in situations that are complex or new
- ME 2.2 Gather a relevant clinical history
- ME 2.2 Formulate a differential diagnosis based on the pathological examination
- ME 2.2 Select ancillary techniques judiciously in a resource-effective and ethical manner
- ME 3.4 Use digital microscopy and interpret gross and microscopic digital images, including digitized and scanned slides
- ME 2.2 Establish a diagnosis that takes into account clinical correlations
- ME 4.1 Determine the need and timing of referral to another specialist and/or second opinion
- ME 1.4 Complete pathology reports within appropriate turnaround times
Communicator
- COM 4.1 Prepare clear, concise, comprehensive, and timely written reports for surgical pathology
- COM 4.1 Integrate information from ancillary studies and other sources into the pathology report
- COM 4.1 Use synoptic and other standardized reporting formats as appropriate
Collaborator
- COL 1.3 Convey information from the pathology assessment to clinicians in a manner that enhances patient management
- COL 2.1 Delegate tasks and responsibilities in an appropriate and respectful manner
Health Advocate
- HA 1.1 Respond to individual patient diagnostic needs and issues as part of patient care
Scholar
- S 3.1 Generate focused questions that address practice uncertainty and knowledge gaps
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-7
Providing intraoperative consultations
Key features and assessment plan
- This EPA focuses on the elements of an intra-operative consultation, from specimen handling to clear and effective communication of results to the clinical team. - This includes reviewing the clinical information, handling and triaging the tissue, preparing and analyzing the various preparations (touch-preparation, frozen section, etc.), providing a clinically relevant interpretation, and conveying the results to the clinical team. - This EPA includes working within an appropriate turn-around-time. - Examples of requests relevant to this EPA include intraoperative consultations for tumour margins, medical kidney biopsy/assessment, tumour specific protocols, and lymphoma protocol.
Direct observation by pathologist Use Form 1. Form collects information on: - Tissue type (write in): - Indications for procedure (write in): Collect 10 observations of achievement - Variety of tissue types and indications - At least 3 different observers
Suggested observations: 10
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 1.3 Apply knowledge of indications, contraindications and limitations of frozen sections
- ME 2.2 Gather a relevant clinical history
- ME 1.3 Apply knowledge about most appropriate method of intraoperative assessment (gross examination only vs frozen sections vs cytologic examination)
- ME 2.2 Assess specimen adequacy in surgical and cytology specimens
- ME 3.4 Select representative tissue from larger specimens for intraoperative consultation and embed appropriately
- ME 3.4 Prepare frozen sections, including imprint cytology specimens when relevant, and review for diagnosis
- ME 5.2 Apply safe practices in the laboratory, intraoperative consultation suite, and autopsy suite to minimize occupational risk
- ME 1.3 Apply knowledge of the appearance of normal cells in cytologic preparations
- ME 1.3 Apply knowledge of gross and microscopic appearances of tissues in disease states
- ME 1.3 Apply knowledge of cytological appearance of cells in disease states
- ME 1.3 Apply knowledge of the principles of and indications for ancillary diagnostic techniques
- ME 2.2 Formulate a differential diagnosis based on the pathological examination
- ME 2.2 Establish a diagnosis that takes into account clinical correlations
- ME 3.4 Establish and implement a plan for post-procedure handling of tissue
Collaborator
- COL 1.2 Discuss indications for appropriate use of intra-operative and urgent consultations
- COL 1.2 Work effectively with laboratory technologists and pathology assistants, directing their assistance
- COL 1.2 Interact effectively with surgeons during intraoperative consultations
- COL 1.3 Convey information from the pathology assessment to clinicians in a manner that enhances patient management
- COL 1.3 Convey diagnostic uncertainty and discuss deferral of diagnosis when needed
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-8
Presenting in multidisciplinary rounds
Key features and assessment plan
- This EPA focuses on the pathologist's role within and contributions to the interprofessional team regarding patient care and management. - Examples of rounds include grand rounds, tumour board, and radiology/pathology correlation rounds. - This includes reviewing and synthesizing case histories, selecting representative sections for presentation, seeking external consultation and consensus in diagnosis when appropriate, and conveying the pathologic findings to the interprofessional teams long with the implications for prognosis and treatment.
Direct observation by supervising pathologist, TTP trainee or other clinicians Use Form 1. Form collects information on: - Multidisciplinary round specialty (write in): - Observer role: pathologist; TTP trainee; other clinician Collect 5 observations of achievement - Multidisciplinary rounds of at least 3 different specialties - At least 2 different observers - At least 1 pathologist
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 1.3 Apply a broad base and depth of knowledge in clinical and biomedical sciences relevant to General Pathology
- ME 1.4 Synthesize cases for discussion at multidisciplinary rounds
- ME 2.3 Provide diagnostic and prognostic information to help clinicians establish goals of care
- ME 2.2 Select and interpret appropriate investigations based on a differential diagnosis
- ME 2.4 Guide therapy decisions with a complete and accurate pathology report
Collaborator
- COL 1.3 Convey information from the pathology assessment to clinicians in a manner that enhances patient management
- COL 1.3 Support clinical colleagues in the development and implementation of a management plan, as appropriate
- COL 1.3 Contribute effectively at multidisciplinary rounds, presenting and discussing pathology findings
Health Advocate
- HA 1.1 Respond to individual patient diagnostic needs and issue as part of patient care
Scholar
- S 3.3 Critically evaluate the literature
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-9
Managing microbiological testing relevant to a community setting
Key features and assessment plan
- This EPA focuses on the role of the general pathologist in the microbiology lab - This includes: o Performing and/or overseeing the identification and reporting of antimicrobial susceptibility of common pathogenic microorganisms (bacteria, fungi, viruses, parasites) from routine specimens with emphasis on the clinical-pathological context o Advocating for and modelling appropriate laboratory safety practices o Acting as an effective consultant for clinical queries regarding specimen collection, test selection, and test interpretation as to the clinical significance of the result o Demonstrating awareness of the limits of laboratory reporting, and the role of referral to other testing facilities (e.g., public health laboratory) o Adhering to requirements related to reportable infections, and demonstrating awareness of the role of the laboratory in public health and facility infection control efforts - The observation of this EPA is divided into two parts: laboratory workup; and providing clinical consultation
Part A: Laboratory workup Direct and indirect observation by supervisor (medical microbiologist, medical microbiology subspecialty trainee, general pathologist, or clinical chemist (for serology, if applicable), infectious disease subspecialty trainee, or TTP trainee) or directly by technologist Use Form 1. Form collects information on: - Microorganism: bacteriology; virology; parasitology; mycology; serology - Specimen type: blood; CSF; urine; other body fluids; stool; genital; respiratory; wound/skin swab; surgical/tissue specimen - Type of activity (select all that apply): specimen workup; antimicrobial sensitivity; performance of gram stain; performance of other procedure; test interpretation; quality control/assurance - Results (write in): Collect 12 observations of achievement - At least 12 unique microorganisms - At least 5 bacteriology, with interpretation of antimicrobial sensitivity tests results - At least 3 interpretations of positive viral serology specimens - At least 1 viral hepatitis - At least 2 each of parasitology and mycology - A variety of specimen types - At least 5 performances of gram stains with test interpretations - At least 3 observers Part B: Providing clinical consultation Direct observation of case presentation by microbiologist, general pathologist, TTP trainee or ID fellow Use Form 1. Form collects information on: - Reason for consult: test selection; specimen collection; test interpretation; other Collect 2 observations of achievement - At least 2 different reasons for consultation - At least 2 different observers
Suggested observations: 12
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Microorganism
- bacteriology
- virology
- parasitology
- mycology
- serology
Specimen type
- blood
- CSF
- urine
- other body fluids
- stool
- genital
- respiratory
- wound/skin swab
- surgical/tissue specimen
Type of activity
- specimen workup
- antimicrobial sensitivity
- performance of gram stain
- performance of other procedure
- test interpretation
- quality control/assurance
Medical Expert
- Part A: ME 3.3 Triage investigations, taking into account clinical urgency and available resources
- Part A: ME 1.3 Apply knowledge of the microscopic appearance and culture characteristics of bacterial organisms, and the use of diagnostic and antimicrobial susceptibility testing
- Part A: ME 1.3 Apply knowledge of common viral, fungal, and parasitic organisms and the use of serologic and culture investigations for diagnosis
- Part A: ME 2.2 Perform morphologic assessment of microorganisms
- Part A: ME 2.2 Analyze microbiologic data and correlate to clinical information
- Part A: ME 2.4 Identify microorganisms, and report antimicrobial susceptibility
- Part A: ME 4.1 Determine the need to send out a specimen for further testing
- Part A: ME 5.2 Apply safe practices in the laboratory, intraoperative consultation suite, and autopsy suite to minimize occupational risk
- Part A: ME 5.1 Adhere to standard operating procedures (SOP)
- Part A: ME 5.1 Take appropriate actions to address a breach in quality or safety
- Part B: ME 2.2 Gather and synthesize patient information to establish the clinical question
- Part B: ME 2.2 Develop a differential diagnosis
- Part B: ME 2.2 Analyze microbiologic data and correlate to clinical information
- Part B: ME 2.4 Provide advice regarding appropriate use of diagnostic testing
- Part B: ME 2.4 Provide an interpretation of the clinical significance of test results
Communicator
- Part A: COM 4.1 Convey critical values or unexpected results in a timely manner
Collaborator
- Part B: COL 1.1 Establish positive relationships with other members of the health care team
- Part B: COL 1.3 Provide advice to clinical colleagues regarding specimen procurement and handling
- Part B: COL 1.3 Support clinical colleagues in the development and implementation of a management plan, as appropriate
- Part B: COL 1.3 Communicate effectively with physicians and other colleagues in the health care professions
Health Advocate
- Part B: HA 1.1 Respond to individual patient diagnostic needs and issues as part of patient care
Professional
- Part A: P 3.1 Adhere to regulations regarding mandatory reporting of communicable disease
- Part B: P 3.1 Adhere to regulations regarding mandatory reporting of communicable disease
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-10
Triaging, interpreting, and reporting peripheral blood smears, bone marrows, lymph nodes and other solid tis…
Key features and assessment plan
- This EPA focuses on providing diagnostic reports for a variety of specimens, with integration of clinical, laboratory, and morphologic findings, and timely selection and interpretation of ancillary testing. - Ancillary testing may include high performance liquid chromatography (HPLC), sickle solubility testing, Hb electrophoresis, serum protein electrophoresis, general chemistry testing, immunohistochemistry, flow cytometry, cytogenetics, or molecular studies, as relevant to the case. - This EPA includes recognizing indications for secondary consultation (e.g., specialist referral, consensus rounds) as appropriate. - The observation of this EPA is divided into three parts: peripheral smears; bone marrow aspirates and biopsies; lymph nodes, lymphoid associated tissue, and other solid tissues.
Part A: Peripheral smears Direct and/or indirect observation by pathologist, TTP trainee, clinician practicing hematopathology or medical laboratory technologist Use Form 1. Form collects information on: - Diagnosis (write in): Collect 12 observations of achievement - A variety of diagnoses including critical values - At least 2 observers, one of which must be a pathologist or clinician practicing hematopathology Part B: Bone marrow aspirates and biopsies Direct and/or indirect observation by pathologist, TTP trainee, clinician practicing hematopathology or medical laboratory technologist Use Form 1. Form collects information on: - Category: non-neoplastic; myeloproliferative; myelodysplastic; lymphoproliferative; other - Diagnosis (write in): Collect 10 observations of achievement - At least 2 from each category including a mix of diagnoses (max 1 normal) - At least 2 observers, 1 of which must be a pathologist Part C: Lymph nodes, lymphoid associated tissue, and other solid tissues Direct and/or indirect observation by pathologist, TTP trainee, clinician practicing hematopathology or medical laboratory technologist Use Form 1. Form collects information on: - Category: reactive/infectious; Hodgkin lymphoma; Non-Hodgkin lymphoma - Diagnosis (write in): Collect 12 observations of achievement - At least 2 each from category including a mix of diagnoses - At least 2 observers, 1 of which must be a pathologist
Suggested observations: 12
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- Part A: ME 1.3 Apply a broad base and depth of knowledge in clinical and biomedical sciences relevant to General Pathology
- Part A: ME 2.2 Select and/or interpret investigations
- Part A: ME 2.2 Perform morphologic assessment of peripheral blood smears
- Part A: ME 2.2 Formulate a differential diagnosis based on the morphologic assessment
- Part A: ME 1.3 Demonstrate an approach to the diagnosis of anemia
- Part A: ME 2.2 Establish a diagnosis that takes into account clinical correlations
- Part A: ME 3.3 Triage investigations, taking into account clinical urgency and available resources
- Part A: ME 4.1 Determine the need and timing of referral to another specialist and/or second opinion
- Part B: ME 1.3 Apply a broad base and depth of knowledge in clinical and biomedical sciences relevant to General Pathology
- Part B: ME 2.2 Perform morphological assessment of bone marrow specimens, including differential cell counts
- Part B: ME 2.2 Formulate a differential diagnosis based on the morphological assessment
- Part B: ME 1.3 Demonstrate an approach to the diagnosis of anemia
- Part B: ME 2.2 Assess specimen adequacy for ancillary testing
- Part B: ME 2.2 Select ancillary studies based on an appreciation of the diagnostic possibilities, the clinical context, and the relevance and capabilities of available technologies
- Part B: ME 2.2 Interpret the results of flow cytometry
- Part B: ME 3.3 Triage investigations, taking into account clinical urgency and available resources
- Part B: ME 4.1 Determine the need and timing of referral to another specialist and/or second opinion
- Part B: ME 2.2 Establish a diagnosis that takes into account clinical correlations
- Part C: ME 1.3 Apply a broad base and depth of knowledge in clinical and biomedical sciences relevant to General Pathology
- Part C: ME 2.2 Perform morphologic assessment of lymph node and lymphoid associated tissue
- Part C: ME 2.2 Formulate a differential diagnosis based on the morphologic assessment
- Part C: ME 2.2 Assess specimen adequacy for ancillary testing
- Part C: ME 2.2 Select ancillary studies based on an appreciation of the diagnostic possibilities, the clinical context, and the relevance and capabilities of available technologies
- Part C: ME 3.3 Triage investigations, taking into account clinical urgency and available resources
- Part C: ME 2.2 Establish a diagnosis that takes into account clinical correlations
- Part C: ME 4.1 Determine the need and timing of referral to another specialist and/or second opinion
Communicator
- Part A: COM 4.1 Formulate comprehensive and clinically meaningful reports
- Part B: COM 4.1 Formulate comprehensive and clinically meaningful reports
- Part C: COM 4.1 Formulate comprehensive and clinically meaningful reports
- Part C: COM 4.1 Integrate information from ancillary studies and other sources into the pathology report
Collaborator
- Part A: COL 3.1 Determine when a case should be transferred to another pathologist with differing expertise
- Part A: COL 1.3 Convey information from the diagnostic assessment in a manner that enhances patient care
- Part B: COL 1.3 Convey information from the diagnostic assessment in a manner that enhances patient care
- Part C: COL 1.3 Convey information from the diagnostic assessment in a manner that enhances patient care
Leader
- Part A: L 2.1 Use clinical judgment to minimize wasteful practices
- Part B: L 2.1 Use clinical judgment to minimize wasteful practices
- Part C: L 2.1 Use clinical judgment to minimize wasteful practices
Professional
- Part A: P 2.2 Demonstrate a commitment to patient safety and quality improvement initiatives
- Part B: P 2.2 Demonstrate a commitment to patient safety and quality improvement initiatives
- Part C: P 2.2 Demonstrate a commitment to patient safety and quality improvement initiatives
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-11
Selecting, interpreting and reporting tests for common hemoglobinopathies, enzymopathies, and membranopathies
Key features and assessment plan
- This EPA focuses on the laboratory diagnosis of red cell disorders, and includes integration of clinical and laboratory findings, and judicious and timely selection and interpretation of ancillary tests. - Relevant presentations include anemia, microcytosis, hemolysis and abnormal red cell morphology, and relevant diagnoses include thalassemia, sickle cell disease, spherocytosis, and G6PD deficiency. - Ancillary testing may include high performance liquid chromatography (HPLC), sickle solubility testing, Hb electrophoresis, peripheral smear morphology, CBC indices, flow cytometry, or molecular studies as relevant to the case.
Direct and/or indirect observation by pathologist, TTP trainee, or clinician practicing hematopathology/transfusion medicine with input from medical laboratory technologist Use Form 1. Form collects information on: - Category: normal; hemoglobinopathy; enzymopathy; membranopathy - Diagnosis (write in): Collect 5 observations of achievement - Variety of cases, including a maximum of one normal sample
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Category
- normal
- hemoglobinopathy
- enzymopathy
- membranopathy
Medical Expert
- ME 1.3 Apply a broad base and depth of knowledge in clinical and biomedical sciences relevant to General Pathology
- ME 1.3 Apply knowledge of the principles of test methodology and instrumentation in a hematology laboratory
- ME 2.2 Select and interpret investigations based on a differential diagnosis
- ME 2.2 Select ancillary studies based on an appreciation of the diagnostic possibilities, the clinical context, and the relevance and capabilities of available technologies
- ME 3.3 Triage investigations, taking into account clinical urgency and available resources
- ME 2.2 Establish a diagnosis that takes into account clinical correlations
- ME 4.1 Determine the need and timing of referral to another specialist and/or second opinion
Communicator
- COM 4.1 Formulate comprehensive and clinically meaningful reports
Collaborator
- COL 1.3 Convey information from the diagnostic assessment in a manner that enhances patient care
Leader
- L 2.1 Use clinical judgment to minimize wasteful practices
Professional
- P 2.2 Demonstrate a commitment to patient safety and quality improvement initiatives
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-12
Diagnosing and reporting common coagulopathies
Key features and assessment plan
- This EPA focuses on selection, interpretation, and reporting of routine and special coagulation tests, and molecular testing as relevant. - This includes gathering relevant clinical history (including medications) for presentations of bleeding and thrombosis, integrating clinical and laboratory findings, ordering appropriate screening and diagnostic testing, and applying an understanding of testing methodology. - Diagnoses relevant to this EPA include disorders of platelet function, clotting factors, and blood vessels. Examples include hemophilia A, lupus inhibitor, therapy related/medication related issues, and both congenital and acquired disorders. - Diagnostic tests relevant to this EPA include PT/INR, aPTT, platelet function tests, quantitative factors assays, qualitative factors assays, morphologic assessment, and molecular studies.
Direct and indirect observation by pathologist, TTP trainee, clinical hematologist practicing hematopathology, or medical laboratory technologists Use Form 1. Form collects information on: - Presentation: bleeding; thrombosis; drug monitoring; asymptomatic; abnormal lab value - Category: platelet disorder; factor disorder; vascular disorder; multifactorial - Diagnosis (write in): Collect 10 observations of achievement - A variety of bleeding and thrombotic disorders - At least 2 different observers - At least 5 observations by pathologist or hematologist
Suggested observations: 10
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Presentation
- bleeding
- thrombosis
- drug monitoring
- asymptomatic
- abnormal lab value
Category
- platelet disorder
- factor disorder
- vascular disorder
- multifactorial
Medical Expert
- ME 2.2 Gather a relevant clinical history
- ME 1.3 Demonstrate an approach to the diagnosis of bleeding and thrombotic disorders
- ME 1.3 Apply a broad base and depth of knowledge in clinical and biomedical sciences relevant to General Pathology
- ME 1.3 Apply knowledge of the principles of test methodology and instrumentation in a hematology laboratory
- ME 2.2 Select and interpret investigations based on a differential diagnosis
- ME 2.2 Select ancillary studies based on an appreciation of the diagnostic possibilities, the clinical context, and the relevance and capabilities of available technologies
- ME 3.3 Triage investigations, taking into account clinical urgency and available resources
- ME 2.2 Establish a diagnosis that takes into account clinical correlations
- ME 4.1 Determine the need and timing of referral to another specialist and/or second opinion
Communicator
- COM 4.1 Formulate comprehensive and clinically meaningful reports
- COM 4.1 Convey critical values or unexpected results in a timely manner
Collaborator
- COL 1.3 Convey information from the diagnostic assessment in a manner that enhances patient care
Leader
- L 2.1 Use clinical judgment to minimize wasteful practices
Professional
- P 2.2 Demonstrate a commitment to patient safety and quality improvement initiatives
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-13
Diagnosing and managing routine clinical and laboratory problems in transfusion medicine
Key features and assessment plan
- This EPA focuses on the role of the General Pathologist in relation to Transfusion Medicine. - This includes interpreting laboratory testing, releasing products for transfusion, providing advice to clinicians, and investigating transfusion reactions. - Interpretation of laboratory testing includes forward and reverse typing, antibody screening and identification, ABO discrepancies, and utilizing other relevant clinical and lab data. - Managing the blood product inventory is an important aspect of this EPA, and includes appropriate collection, storage, modification (i.e., washing, irradiation), distribution, and appropriate utilization. - This EPA includes providing advice on transfusion management in a variety of acute and chronic clinical settings. Examples include surgical bleeding, trauma, transfusion-dependent patients, obstetrical bleeding, hemolytic disease of fetus and newborn, disseminated intravascular coagulation (DIC) and/or thrombotic thrombocytopenic purpura TTP, liver failure, and factor deficiency. - The observation of this EPA is divided into three parts: managing the blood inventory; providing clinical consultation to clinicians; and investigating transfusion reactions.
Part A: Managing the blood inventory Direct observation by pathologist, TTP trainee, clinician practicing transfusion medicine, or transfusion medicine technologist, or indirect observation through post-call debriefing by supervisor with input or feedback from technologists Use Form 1. Form collects information on: - Setting: clinical; simulation - Inventory: blood component; blood product - Category (select all that apply): clinical; laboratory; collection; storage; modification; distribution; utilization/stewardship Collect 5 observations of achievement - A mix of clinical and laboratory scenarios - At least 2 observers - At least 1 pathologist/hematologist Part B: Providing clinical consultation Direct observation by pathologist, TTP trainee, clinician practicing transfusion medicine, or transfusion medicine technologist, or indirect observation through post-call debriefing by supervisor with input or feedback from technologists or clinical staff (e.g., RN, physicians) Use Form 1. Form collects information on: - Setting: clinical; simulation - Category (select all that apply): surgical indication; medical indication; trauma; platelet disorder; factor disorder; immunomodulation; other - Diagnosis (write in): Collect 5 observations of achievement - A mix of clinical and laboratory scenarios incorporating both blood components and products - At least 2 observers - At least 3 by a pathologist or hematologist Part C: Investigating transfusion reactions Direct and/or indirect observation by supervisor Use Form 1. Form collects information on: - Setting: clinical; simulation - Inventory: blood component; blood product - Type of transfusion reaction (write in): Collect 5 observations of achievement
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Setting
- clinical
- simulation
Inventory
- blood component
- blood product
Category
- clinical
- laboratory
- collection
- storage
- modification
- distribution
- utilization/stewardship
Medical Expert
- Part A: ME 1.3 Apply knowledge of immunohematology, including major blood group systems and the role of the human leukocyte antigen (HLA) system
- Part A: ME 1.3 Apply knowledge of common problems of blood-banking, including incompatible cross match, auto- and alloimmune antibodies and their differentiation, and neonatal blood banking issues
- Part A: ME 1.3 Apply knowledge of standards as they apply to the testing and release of blood products
- Part A: ME 1.3 Apply knowledge of current Canadian Blood Services (CBS) policies, procedures, and products, including autologous and directed donations
- Part A: ME 2.2 Gather a relevant clinical history
- Part A: ME 2.4 Review and supervise bench level tests, including manual, semi-automated, and automated tests
- Part A: ME 2.2 Select and/or interpret investigations
- Part A: ME 2.4 Assess transfusion orders in relation to appropriateness, risks, and alternatives to transfusion
- Part A: ME 2.4 Modify and/or release blood components and products for clinical use
- Part B: ME 2.2 Gather and synthesize patient information to establish the clinical question
- Part B: ME 2.2 Select and interpret investigations based on a differential diagnosis
- Part B: ME 2.2 Establish a diagnosis that takes into account clinical correlations
- Part B: ME 1.3 Apply knowledge of the therapeutic use of blood components
- Part B: ME 2.4 Assess transfusion orders in relation to appropriateness, risks, and alternatives to transfusion
- Part C: ME 1.3 Apply knowledge of the principles of investigation and classification of adverse reactions to blood component therapy
- Part C: ME 2.2 Gather a relevant clinical history
- Part C: ME 2.2 Perform a product review
- Part C: ME 2.2 Select and/or interpret investigations
- Part C: ME 2.2 Determine the classification of the adverse reaction to blood component therapy
- Part C: ME 2.4 Establish the probable cause of the adverse reaction to blood component therapy
- Part C: ME 5.1 Report the adverse reaction, completing the relevant documentation
Communicator
- Part C: COM 2.3 Seek and synthesize relevant information from other sources, including the physician(s) involved
Collaborator
- Part A: COL 1.3 Work effectively with clinical colleagues to assist in the interpretation of laboratory findings in the clinical context
- Part B: COL 1.3 Work effectively with clinical colleagues to assist in the interpretation of laboratory findings in the clinical context
- Part B: COL 1.1 Establish positive relationships with other members of the health care team
- Part B: COL 1.3 Support clinical colleagues in the development and implementation of a management plan, as appropriate
Leader
- Part A: L 2.1 Use clinical judgment to minimize wasteful practices
Health Advocate
- Part B: HA 1.1 Respond to individual patient diagnostic needs and issues as part of patient care
Professional
- Part C: P 3.1 Adhere to regulations governing the safety and surveillance of the blood supply system
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-14
Selecting, correlating and interpreting common genomic/molecular pathology test results
Key features and assessment plan
- This EPA focuses on the role of genomic/molecular pathology studies in general pathology practice, across all its domains - This EPA includes selecting these ancillary studies, and interpreting the findings in the context of clinical history, specimen type, and other diagnostic results
Direct observation by pathologist, geneticist, TTP trainee, technologist, or clinician Use Form 1. Form collects information on: - Activity (select all that apply): test selection; result interpretation - Specimen type: formalin fixed paraffin embedded (FFPE) tissue; fresh/frozen tissue; blood/bone marrow; other - Test type/methodology: Polymerase Chain Reaction (PCR); next generation sequencing (NGS); karyotype; fluorescence in situ hybridization (FISH) /chromogenic in situ hybridization (CISH); ploidy - Case: hematology; microbiology; biochemistry; surgical pathology; other Collect 25 observations of achievement - At least 10 cases of test selection, including - At least 2 each of FFPE tissue, fresh/frozen tissue and blood/bone marrow tissue - At least 10 result interpretations, including - At least 1 of PCR, karyotype, FISH/CISH - A variety of hematology, microbiology, and biochemistry cases
Suggested observations: 25
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Activity
- test selection
- result interpretation
Specimen type
- formalin fixed paraffin embedded (FFPE) tissue
- fresh/frozen tissue
- blood/bone marrow
- other
Test type/methodology
- Polymerase Chain Reaction (PCR)
- next generation sequencing (NGS)
- karyotype
- fluorescence in situ hybridization (FISH) /chromogenic in situ hybridization (CISH)
- ploidy
Case
- hematology
- microbiology
- biochemistry
- surgical pathology
- other
Medical Expert
- ME 1.3 Apply knowledge of the principles of cell biology, immunology, genetics, and pathogenic mechanisms, and the changes that occur in disease states
- ME 1.3 Apply knowledge of general concepts related to the human genome, human genes, and inheritance of DNA
- ME 1.3 Apply knowledge of general concepts of inherited and somatic disease
- ME 1.3 Apply knowledge of the principles of and indications for ancillary diagnostic techniques
- ME 1.3 Apply knowledge of appropriate sample requirements and handling
- ME 2.1 Identify and explore clinical issues to be addressed in the pre-analytical, analytical and post-analytical handling of a case
- ME 2.2 Select additional testing based on an appreciation of the diagnostic possibilities, the clinical context, and the relevance and capabilities of available technologies
- ME 4.1 Coordinate the use of multiple diagnostic investigations so as to ensure complementarity and efficiency
- ME 3.3 Prioritize routine and ancillary investigations when specimen adequacy is limited
- ME 5.1 Recognize sources of analytical error for various molecular tests
- ME 2.2 Interpret molecular diagnostic test results together with available clinical and laboratory data
Communicator
- COM 4.1 Integrate molecular results into the laboratory report
Leader
- L 2.1 Utilize genetic testing resources effectively to balance costs with potential utility of results
Health Advocate
- HA 1.2 Describe the role of molecular methods used to screen for inherited/familial cancer syndromes
Professional
- P 1.3 Describe the role and demonstrate an understanding of the ethics of genetic screening in family planning and for hereditary cancers
- P 3.1 Ensure compliance with privacy regulations as they apply to the use of genetic information
- P 3.1 Recognize the medicolegal implications in the practice of genetics
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-15
Managing, interpreting and reporting of gynecologic and non-gynecologic cytology specimens
Key features and assessment plan
- This EPA focuses on all aspects of the examination of a cytopathological specimen - This includes applying specimen and requisition adequacy criteria in the decision to accept or reject a cytology specimen, and triaging for ancillary testing in consultation with the clinical team. - This EPA also includes participation in preparing gynecological and non-gynecological specimens and ensuring the quality of slides generated, including an assessment of stain quality, as well as a complete cytopathological interpretation that reflects relevant clinical features and cytopathologic findings, including ancillary test findings and clinical recommendations, as appropriate. - The observation of this EPA is divided into two parts: specimen adequacy and processing; and interpretation and reporting
Part A: Specimen adequacy and processing Direct observation and/or case discussion by technologist, pathologist, or TTP trainee Use Form 1. Form collects information on: - Observation: direct; indirect - Specimen type: gynecological; FNA; fluid (pleural, peritoneal, urine, CSF etc.); endoscopic ultrasound (EUS); endobronchial ultrasound (EBUS) Collect 5 observations of achievement - At least 3 different specimen types - At least 2 different observers Part B: Interpretation and reporting Case review with pathologist or TTP trainee Use Form 1. Form collects information on: - Specimen type: gynecological; FNA; fluid (pleural, peritoneal, urine, CSF etc.); endoscopic ultrasound (EUS); endobronchial ultrasound (EBUS) Collect 40 observations of achievement - At least 20 gynecological - At least 10 FNA (a mix of specimen type including EUS or EBUS) - At least 10 fluids - At least 3 different observers
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Observation
- direct
- indirect
Specimen type
- gynecological
- FNA
- fluid (pleural, peritoneal, urine, CSF etc.)
- endoscopic ultrasound (EUS)
- endobronchial ultrasound (EBUS)
Medical Expert
- Part A: ME 2.1 Determine if cytology specimens and requisitions meet adequacy criteria
- Part A: ME 2.1 Describe reasons for specimen rejection and the process of rejection documentation
- Part A: ME 5.1 Resolve issues related to specimen misidentification
- Part A: ME 2.1 Identify and explore clinical issues to be addressed in the pre-analytical handling of a cytopathology case
- Part A: ME 2.2 Assess specimen adequacy in surgical and cytology specimens
- Part A: ME 1.3 Apply knowledge of the principles of and indications for ancillary diagnostic techniques
- Part A: ME 3.4 Prepare gynecological and non-gynecological cytology specimens, including staining, cover-slipping, triaging, and storage
- Part A: ME 5.2 Apply safe practices in the laboratory, intraoperative consultation suite, and autopsy suite to minimize occupational risk
- Part B: ME 1.3 Apply knowledge of the appearance of normal cells in cytologic preparations
- Part B: ME 1.3 Apply knowledge of cytological appearance of cells in disease states
- Part B: ME 1.3 Apply knowledge of the principles of and indications for ancillary diagnostic techniques
- Part B: ME 2.1 Identify and explore clinical issues to be addressed in the pre-analytical, analytical and post-analytical handling of a case
- Part B: ME 2.2 Assess specimen adequacy in surgical and cytology specimens
- Part B: ME 2.2 Describe common pitfalls in diagnosis of cytopathological specimens
- Part B: ME 2.2 Establish a diagnosis that takes into account clinical correlations
- Part B: ME 4.1 Determine the need and timing of referral to another specialist and/or second opinion
Communicator
- Part B: COM 4.1 Prepare clear, concise, comprehensive, and timely written reports for cytopathology consultations
- Part B: COM 4.1 Use standardized terminology for reporting results, as relevant
- Part B: COM 4.1 Provide educational notes and recommendations when needed in the report
- Part B: COM 4.1 Convey critical values or unexpected results in a timely manner
Collaborator
- Part A: COL 1.3 Communicate effectively with physicians and other colleagues in the health care professions
Leader
- Part A: L 2.1 Use clinical judgment to minimize wasteful practices
- Part A: L 1.1 Participate in quality control, quality assurance, and quality improvement initiatives
Scholar
- Part B: S 3.4 Integrate best evidence and clinical expertise into decision-making
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-16
Identifying, investigating and resolving pre-analytical, analytical and post- analytical issues in laborator…
Key features and assessment plan
- This EPA focuses on the quality assurance (QA) and quality control (QC) aspects of laboratory management in surgical and clinical pathology. - This includes ongoing routine monitoring such as proficiency testing, retrospective review, analyzer-specific QC metrics, turn-around-times, amended report rates, cyto-histo correlation, pos/neg immunohistochemistry controls and special stains, hemolysis, icterus, and lipemia (HIL) indices, daily analyzer-specific QC including Westgard rules etc., and microbiology specific QC as per test availability (molecular, MALDI-TOF, C&S, etc.). - It also includes addressing issues that arise, such as trouble-shooting instrument malfunction or error, responding to complaints, and reviewing breaches in laboratory quality or safety. - It may include communication with clinicians, and/or reporting to patient safety reporting and learning systems, as needed.
Direct and indirect observation by supervisor or TTP trainee Use Form 1. Form collects information on: - Lab discipline: anatomical pathology; hematopathology; medical microbiology; medical biochemistry - Trigger for review: routine monitoring; error; complaint; other Collect 10 observations of achievement - At least 2 from each lab discipline
Suggested observations: 10
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Lab discipline
- anatomical pathology
- hematopathology
- medical microbiology
- medical biochemistry
Trigger for review
- routine monitoring
- error
- complaint
- other
Medical Expert
- ME 1.3 Apply a broad base and depth of knowledge in clinical and biomedical sciences relevant to General Pathology
Communicator
- COM 4.1 Convey critical values or unexpected results in a timely manner
- COM 3.2 Convey and document issues arising from a breach in quality or safety of laboratory practices
Leader
- L 1.4 Apply knowledge of the metrics and measurement systems used to track quality management and safety activities
- L 1.1 Review quality control data
- L 1.1 Identify when a finding or occurrence requires action to ensure quality of laboratory services
- L 1.4 Identify variation/gaps between actual and targeted performance using thresholds
- L 1.1 Apply knowledge of process improvement methodologies
- L 1.1 Formulate and carry out a plan of action
- L 1.1 Reassess the results in the context of quality improvement
- L 2.1 Use clinical judgment to minimize wasteful practices
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Professional
- P 3.1 Adhere to the relevant codes, policies, standards, and laws governing laboratory practice including accreditation standards, standard operating procedures, and Clinical and Laboratory Standards Institute (CLSI) standards
- P 3.3 Participate in intra- and extra-departmental reviews of diagnostic pathology material
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-17
Participating in the selection and validation of new instrumentation, and evaluation of new tests
Key features and assessment plan
- This EPA focuses on the process of selecting and validating new instrumentation. - This includes clinical consultation, methodology comparison, volume and cost comparison, and preparation of a business case and/or request for proposal (RFP). - It may also include establishing reference ranges, quality control, reports, and laboratory information system integration. - The observation of this EPA is based on the resident’s review and synthesis of the work-up and presentation of that information as a part of a business case.
Case discussion with supervisor or lab manager Use Form 1. Form collects information on: - Aspect (select all that apply): clinical utility; analytical (total allowable error/precision/reference range, etc.); financial; setting up QC; investigating proficiency testing options; other Collect 1 observation of achievement - At least 3 aspects
Suggested observations: 1
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Aspect
- clinical utility
- analytical (total allowable error/precision/reference range, etc.)
- financial
- setting up QC
- investigating proficiency testing options
- other
Medical Expert
- ME 1.3 Apply a broad base and depth of knowledge in clinical and biomedical sciences relevant to General Pathology
- ME 1.3 Apply knowledge of method comparison, method validation, and instrument selection
Collaborator
- COL 1.3 Work effectively with individuals responsible for laboratory management and/or hospital administration
Leader
- L 1.4 Map the flow of information in the delivery of laboratory services to identify opportunities to improve or enhance laboratory practice
- L 2.2 Determine cost discrepancies between best practice and current practice
- L 2.1 Demonstrate knowledge of resource-efficient laboratory equipment selection
- L 3.1 Provide recommendations regarding equipment selection and purchasing
- L 3.1 Evaluate emerging technologies with a view to the possibility of integration in the laboratory
Health Advocate
- HA 2.2 Evaluate laboratory practices and test selection to ensure they meet community needs
- HA 2.3 Recognize and respond to situations where health advocacy and application of health care resources is required, including the introduction of improved instrumentation and methodologies to augment community health care
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Professional
- P 3.1 Adhere to the relevant codes, policies, standards, and laws governing laboratory practice including accreditation standards, standard operating procedures, and Clinical and Laboratory Standards Institute (CLSI) standards
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-18
Ensuring appropriate use of lab resources and test utilization
Key features and assessment plan
- This EPA focuses on active laboratory stewardship, providing services that are clinically appropriate and cost effective. - This includes encouraging best practices, advocating for evidence-based test ordering, promoting cost effective diagnostic strategies, and demonstrating familiarity with commonly employed utilization management techniques. - Examples relevant to this EPA include deciding on the necessity of after-hours call backs, appropriately choosing ancillary studies, determining appropriate laboratory testing menus (i.e., which tests to offer in house vs refer out), advising clinicians on appropriate testing and actively discouraging/preventing inappropriate utilization. - This EPA may be observed in simulation (hypothetical scenario).
Direct or indirect observation by supervisor or TTP trainee Use Form 1. Form collects information on: - Category: clinical consult; laboratory initiated - Lab discipline: anatomical pathology; hematopathology; medical microbiology; medical biochemistry - Specific scenario (write in): Collect 5 observations of achievement - At least 2 observers, 1 of which must be a pathologist or laboratory physician
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Category
- clinical consult
- laboratory initiated
Lab discipline
- anatomical pathology
- hematopathology
- medical microbiology
- medical biochemistry
Medical Expert
- ME 1.3 Apply a broad base and depth of knowledge in clinical and biomedical sciences relevant to General Pathology
- ME 3.1 Integrate all sources of information to develop an investigational plan that is safe, patient-centred, cost effective, and considers the risks and benefits of all approaches
- ME 3.3 Advocate for evidence informed use of investigations with consideration of urgency and available resources
Collaborator
- COL 1.3 Provide consultative services to clinical colleagues regarding appropriate investigations
Leader
- L 2.1 Apply practice-based and system-based rules for resource allocation
- L 2.1 Use clinical judgment to minimize wasteful practices
- L 2.2 Optimize practice patterns for cost-effectiveness and cost control
Health Advocate
- HA 1.1 Respond to the health needs of individual patients
Professional
- P 2.1 Demonstrate a commitment to the promotion of the public good in health care, including stewardship of resources
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-19
Providing routine biochemistry clinical consultations
Key features and assessment plan
- This EPA focuses on acting as an effective consultant for clinical queries regarding specimen collection, test selection, and test interpretation. - This includes professional and timely communication with other lab staff and the clinical/medical care team, advocating for appropriate utilization of lab tests, and demonstrating medical expert knowledge appropriate to the consultation (testing algorithms, etc.). - The observation of this EPA may be based on direct observation by supervisor or indirect observation by senior lab technologists providing input to the supervisor.
Direct and/or indirect observation by supervisor Use Form 1. Form collects information on: - Specimen type (write in): - Indication for consultation (write in): Collect 3 observations of achievement - A variety of indications for consultation
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 1.3 Apply a broad base and depth of knowledge in clinical and biomedical sciences relevant to General Pathology
- ME 2.2 Gather and synthesize patient information to establish the clinical question
- ME 2.4 Provide advice regarding appropriate use of diagnostic testing
- ME 1.3 Apply knowledge of the availability of testing in community or regional hospital laboratories
- ME 2.4 Provide an interpretation of the clinical significance of test results
Collaborator
- COL 1.1 Establish positive relationships with other members of the health care team
- COL 1.3 Provide advice to clinical colleagues regarding specimen procurement and handling
- COL 1.3 Support clinical colleagues in the development and implementation of a management plan, as appropriate
- COL 1.3 Communicate effectively with physicians and other colleagues in the health care professions
Health Advocate
- HA 1.1 Respond to individual patient diagnostic needs and issues as part of patient care
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-20
Interpreting and reporting biochemistry testing
Key features and assessment plan
- This EPA focuses on the role of the General Pathologist in biochemistry diagnostics. - This includes interpreting and reporting individual studies, including serum and urine protein electrophoreses with or without free light chain testing, urine and joint crystal analysis, and other tests requiring pathologist review (e.g., therapeutic drug monitoring and clinical toxicology). - This EPA also includes understanding and developing reflexive/reflective testing and test pathways.
Direct observation of case interpretation and sign-out by pathologist or medical laboratory technician Use Form 1. Form collects information on: - Specimen type: serum protein electrophoresis; urine protein electrophoresis; joint crystal; urine crystal; therapeutic drug monitoring; clinical toxicology; other - Diagnosis (write in): - Case discussion (e.g., reflexive, reflective) (write in): Collect 10 observations of achievement - At least 5 electrophoresis, including at least 3 monoclonal gammopathies - At least 2 joint aspirates for crystals, including at least 1 positive for uric acid/gout - At least 1 case discussion about reflective/reflexive testing - At least 1 case discussion about TDM or clinical toxicology - At least 6 must be observed by pathologist
Suggested observations: 10
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Specimen type
- serum protein electrophoresis
- urine protein electrophoresis
- joint crystal
- urine crystal
- therapeutic drug monitoring
- clinical toxicology
- other
Medical Expert
- ME 2.2 Interpret protein electrophoresis and immunofixation studies
- ME 2.2 Interpret therapeutic drug monitoring or clinical toxicology studies
- ME 2.2 Perform morphologic assessment of urine and body fluids
- ME 2.2 Establish a diagnosis that takes into account clinical correlations
- ME 5.2 Adhere to quality management processes throughout the pre-analytic, analytic, and post-analytic phases
- ME 1.3 Apply knowledge of reflexive/reflective testing and test pathways
Communicator
- COM 4.1 Convey critical values or unexpected results in a timely manner
Collaborator
- COL 1.3 Work effectively with clinical colleagues to assist in the interpretation of laboratory findings in the clinical context
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-21
Providing formal and informal teaching
Key features and assessment plan
- This EPA includes both presentations in formal settings and the informal teaching that occurs as part of clinical work and supervision. - Formal presentations may include journal club, half-day presentations, and clinicopathologic correlation rounds, including tumour boards and radiology- pathology correlation rounds. - Teaching in informal settings includes slide review, multihead/consensus rounds, teaching during gross dissection/autopsy and other informal teaching for medical students, junior residents, or laboratory staff/pathology assistants. - The observation of this EPA is divided into two parts: formal teaching; and informal teaching.
Part A: Formal teaching Direct observation by supervisor, with formal (i.e., collated evaluation) or informal feedback from the audience Use Form 1. Form collects information on: - Topic (write in): Collect at least 2 observations of achievement Part B: Informal teaching Direct and/or indirect observation by supervisor with input from learners Use Form 1. Form collects information on: - Type of informal teaching session (e.g., slide review, grossing) (write in): - Topic/diagnosis (write in): Collect at least 2 observations of achievement
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Scholar
- Part A: S 2.4 Identify the learning needs and desired learning outcomes of others
- Part A: S 2.4 Develop learning objectives for a teaching activity
- Part A: S 3.3 Critically evaluate the literature
- Part A: S 3.4 Integrate best evidence and clinical expertise
- Part A: S 2.4 Present the information in an organized manner
- Part A: S 2.4 Use audiovisual aids effectively
- Part A: S 2.4 Provide adequate time for questions and discussion
- Part B: S 2.1 Use strategies for deliberate, positive role-modelling
- Part B: S 2.2 Create a positive learning environment
- Part B: S 2.4 Identify the learning needs and desired learning outcomes of others
- Part B: S 2.3 Supervise learners to ensure they work within limitations, seeking guidance and supervision when needed
- Part B: S 2.4 Present the information in an organized manner
- Part B: S 2.4 Provide adequate time for questions and discussion
- Part B: S 2.4 Provide useful, timely, constructive feedback
Professional
- Part B: P 1.1 Intervene when behaviours toward colleagues and/or learners undermine a respectful environment
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-22
Conducting scholarly work
Key features and assessment plan
- This EPA includes all aspects of performing scholarly work: identification of a question for investigation, literature review, data gathering, data analysis, reflective critique, and dissemination. - The assessment of this EPA is based on the submission of a completed scholarly project and must also include observation of the presentation of the scholarly work at departmental research day, conference or equivalent. - Publication is not required for EPA achievement. - Individual case reports do not meet the standard of this EPA, however case series are acceptable.
Direct and/or indirect observation by supervisor Use Form 4 Collect 1 observation of achievement
Suggested observations: 1
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Leader
- L 4.1 Organize work to manage clinical, scholarly and other responsibilities
Scholar
- S 4.4 Identify, consult, and collaborate with content experts and others in the conduct of scholarly work
- S 4.4 Generate focused questions for scholarly investigation
- S 3.3 Critically evaluate the literature
- S 4.5 Summarize the findings of a literature review
- S 4.4 Select appropriate methods of addressing a given scholarly question
- S 4.2 Identify ethical principles in research
- S 4.4 Collect data for a scholarly project
- S 4.4 Perform data analysis
- S 4.4 Integrate existing literature and findings of data collection
- S 4.4 Identify areas for further investigation
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-23
Performing clinical diagnostic procedures
Key features and assessment plan
- This EPA focuses on the performance of bone marrow and fine needle aspirate procedures. - This includes obtaining informed consent, correlating diagnostic imaging, and clinical presentations with laboratory findings, and the technical skills of the procedure. - This EPA may be observed in a simulation setting.
Direct observation by supervisor Use Form 2. Form collects information on: - Procedure: bone marrow; Fine Needle Aspirate (FNA) - Specimen type (select all that apply): surgical; cytology; hematopathology; microbiology; general - Simulation: yes; no Collect 2 observations of achievement - At least 1 of each procedure
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Procedure
- bone marrow
- Fine Needle Aspirate (FNA)
Specimen type
- surgical
- cytology
- hematopathology
- microbiology
- general
Simulation
- yes
- no
Medical Expert
- ME 3.1 Determine the safety and appropriateness of the procedure
- ME 3.2 Obtain and document informed consent, explaining the risks and rationale for the procedure
- ME 3.4 Demonstrate effective procedure preparation, including patient identification or safety checklist as appropriate
- ME 3.4 Set up and position the patient for the procedure
- ME 3.4 Prepare and cleanse the procedural site
- ME 3.4 Maintain universal precautions
- ME 3.4 Perform procedures in a skilful and safe manner
- ME 3.4 Seek assistance as needed
- ME 3.4 Document procedures accurately, including adequacy of specimen obtained and the presence/absence of complications
- ME 3.4 Establish and implement a plan for post-procedure care
- ME 3.4 Recognize and manage complications
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
Transition to Practice
TTP-1
Leading and managing the daily operations of the laboratory, including a full workload of cases representin…
Key features and assessment plan
- The observation of this EPA is based on a day’s work. - This includes the review and sign-out of a full daily workload for a general pathologist, including participation in normal rotation for surgical pathology, cytopathology, and clinical pathology labs. - This EPA includes fair and equal contribution to departmental work including teaching, committee work, and multidisciplinary rounds (e.g., oncology). - This EPA also includes participation in departmental slide review meetings (e.g., daily/weekly difficult case review with colleagues and handling QA/QC issues). - The observation of this EPA is divided into two parts: managing the caseload; and supervising the lab.
Part A: Managing the caseload Direct observation and review of reports, internal consultations, and/or case discussion by supervisor Use Form 1. Form collects information on: - Lab discipline: surgical pathology; cytopathology; autopsy pathology; biochemistry; microbiology; hematopathology; transfusion medicine; hemostasis and coagulation; molecular pathology Collect 12 observations of achievement - At least 2 each of surgical pathology, hematopathology, biochemistry, and microbiology - At least 2 observers from each laboratory domain (i.e., surgical pathology, hematopathology, biochemistry, and microbiology) Part B: Supervising the lab Supervisor completes observation form based on input from other observers: pathology assistants, MLAs/MLTs, secretarial/administrative staff, morgue technicians, other residents, and junior learners Use Form 3. Form collects information on: - Lab discipline: surgical pathology; cytopathology; autopsy pathology; biochemistry; microbiology; hematopathology; transfusion medicine; hemostasis and coagulation; molecular pathology - Observer role (select all that apply): pathology assistant; MLAs/MLT; secretarial/administrative staff; morgue technician; other resident; junior learner; other Collect feedback on at least 6 occasions - At least 2 each of surgical pathology and hematopathology - At least 1 each of biochemistry and microbiology - At least 2 observers on each occasion
Suggested observations: 12
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Lab discipline
- surgical pathology
- cytopathology
- autopsy pathology
- biochemistry
- microbiology
- hematopathology
- transfusion medicine
- hemostasis and coagulation
- molecular pathology
Medical Expert
- Part A: ME 1.1 Demonstrate a commitment to high-quality care
- Part A: ME 1.5 Set priorities, triage, and manage the workload within accepted turnaround times
- Part A: ME 1.5 Carry out professional duties in the face of multiple competing demands
- Part A: ME 5.1 Resolve issues related to a breach in quality or safety of laboratory practices
- Part A: ME 1.4 Perform timely, accurate diagnostic assessments
- Part A: ME 1.6 Demonstrate insight into their own limits of expertise and seek consultation as necessary
- Part B: ME 1.1 Demonstrate a commitment to high-quality care
- Part B: ME 5.2 Adhere to quality management processes throughout the pre-analytic, analytic, and post-analytic phase
- Part B: ME 5.2 Apply safe practices in the laboratory, intraoperative consultation suite, and autopsy suite to minimize occupational risk
Communicator
- Part A: COM 4.1 Formulate comprehensive and clinically meaningful reports
Collaborator
- Part A: COL 1.2 Work effectively with other health professionals
- Part B: COL 1.2 Recognize and respect the scope of practice and expertise of other health professionals in the laboratory
- Part B: COL 1.3 Communicate effectively with other health care professionals
Leader
- Part A: L 4.2 Describe the principles of workload measurement within the laboratory
- Part A: L 2.1 Allocate health care resources for optimal patient care
- Part A: L 3.1 Supervise and provide clinical direction of the laboratory
- Part B: L 3.1 Provide guidance and support for questions arising in the laboratory
Scholar
- Part A: S 3.4 Integrate best evidence and clinical expertise into decision-making
Professional
- Part A: P 1.1 Exhibit appropriate professional behaviours
- Part A: P 4.3 Provide mentorship to residents and colleagues
- Part A: P 2.2 Demonstrate a commitment to patient safety and quality improvement initiatives
- Part B: P 1.1 Exhibit appropriate professional behaviours
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTP-2
Functioning independently on call
Key features and assessment plan
- This EPA focuses on being accessible to requests for assistance from clinical and lab colleagues, providing assistance, and ensuring that the request has been addressed, including seeking additional help/guidance when needed, and maintaining a professional manner in all interactions. - This includes considerations of laboratory utilization and resource stewardship. - The observation of this EPA is based on reviewing cases with a supervisor, feedback from those initiating a call or request, as well as personal reflection. - The observation of this EPA is divided into three parts: issue/case management; working with the requesting physician/colleague; and the resident’s personal reflection.
Part A: Issue/case management Direct observation, case discussion, document review, and/or review of slides by supervisor Use Form 1. Form collects information on: - Lab discipline: anatomical pathology; biochemistry; microbiology; hematopathology - Issue (i.e., clinical question posed by the health professional): [free text] Collect 4 observations of achievement - At least 1 from each discipline Part B: Working with the requesting physician/colleague Supervisor completes observation form based on input from health professionals who initiated calls, including clinicians, MLAs/MLTs, pathology assistants, and/or others Use Form 3 Collect at least 1 observation with feedback from at least 4 observers over the TTP stage Part C: Resident reflection Resident submits post-analytical reflection on their on-call experience to the rotation supervisor for review Use Form 4 Collect 1 narrative statement for each 1 month of call during TTP stage
Suggested observations: 4
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Lab discipline
- anatomical pathology
- biochemistry
- microbiology
- hematopathology
Medical Expert
- Part A: ME 2.2 Gather and synthesize patient information to establish the clinical question
- Part A: ME 1.6 Demonstrate insight into their own limits of expertise and seek consultation as necessary
Collaborator
- Part A: COL 1.3 Support clinical colleagues in the development and implementation of a management plan, as appropriate
- Part B: COL 2.1 Respond to requests and feedback in a respectful and timely manner
- Part B: COL 1.3 Support clinical colleagues in the development and implementation of a management plan, as appropriate
- Part B: COL 1.3 Communicate effectively with other health care professionals
Leader
- Part A: L 3.1 Provide guidance and support for questions arising in the laboratory
- Part A: L 2.1 Use clinical judgment to allocate resources, such as investigations, blood products or staffing
- Part B: L 3.1 Provide guidance and support for questions arising in the laboratory
Health Advocate
- Part A: HA 1.1 Respond to individual patient diagnostic needs and issues as part of patient care
Scholar
- Part A: S 3.4 Integrate best evidence and clinical expertise into decision-making
- Part C: S 1.2 Identify opportunities for learning and improvement by regularly reflecting on and assessing personal performance using various internal and external data sources
- Part C: S 1.2 Interpret data on personal performance to identify opportunities for learning and improvement
Professional
- Part A: P 1.1 Exhibit appropriate professional behaviours
- Part B: P 1.1 Exhibit appropriate professional behaviours
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTP-3
Leading, implementing and advocating for quality assurance practices
Key features and assessment plan
- This EPA focuses on the role of General Pathologist as the director providing oversight of the quality of lab services. - This includes quality control and assurance, including process excellence (LEAN, six sigma, etc.), external proficiency testing, and appropriate resource utilization and measurement. - It also includes adherence to provincial, national, and international standards and guidelines as appropriate and applicable. - This EPA may be observed in a variety of activities. Examples include review of Levey-Jennings plot, participation in quality control committee, and participation in histo-cytology correlation.
Direct and/or indirect observation by rotation supervisor Use Form 1. Form collects information on: - Lab discipline: anatomical pathology; biochemistry; microbiology; hematopathology - Description of activity: [free text] Collect 4 observations of achievement - At least 1 from each discipline
Suggested observations: 4
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Lab discipline
- anatomical pathology
- biochemistry
- microbiology
- hematopathology
Medical Expert
- ME 1.3 Apply knowledge of the principles of quality assurance pertinent to General Pathology
Collaborator
- COL 1.2 Work effectively with other health care professionals
Leader
- L 1.4 Apply knowledge of the metrics and measurement systems used to track quality management and safety activities
- L 1.1 Apply knowledge of process improvement methodologies
- L 3.1 Develop and review quality control data, and take action
- L 1.1 Provide leadership for quality control, quality assurance, and quality improvement initiatives
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Professional
- P 1.2 Demonstrate a commitment to excellence in all aspects of clinical laboratory practice
- P 3.1 Fulfil and adhere to the standards regulating laboratory practice and accreditation
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTP-4
Developing and implementing a plan for continuing professional development
Key features and assessment plan
- This EPA may include a variety of scenarios. Examples include: a plan to act on the performance gaps identified in another EPA; a plan to prepare for fellowship training; a plan to prepare for practice in a specific setting (e.g., community) and/or a setting requiring distinct skills. - Achievement of this EPA includes providing a) the rationale for a learning plan, b) self-reflection, c) personal needs assessment, d) time management and e) identification of the methods to achieve the personal learning plan such as literature review, clinical training, conference attendance and/or rounds attendance
Supervisor review of resident’s submission of a personal learning plan Use Form 4 Collect 1 observation of achievement
Suggested observations: 1
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Leader
- L 4.2 Examine personal interests and career goals
- L 4.2 Adjust educational experiences to gain competencies necessary for future practice
Scholar
- S 1.2 Interpret data on personal performance to identify opportunities for learning and improvement
- S 1.1 Define learning needs related to personal practice and/or career goals
- S 3.1 Generate focused questions that address practice uncertainty and knowledge gaps
- S 1.1 Create a learning plan that is feasible, includes clear deliverables and a plan for monitoring ongoing achievement
- S 1.1 Identify resources required to implement a personal learning plan
Professional
- P 2.1 Demonstrate a commitment to maintaining and enhancing competence
Case description
Feedback provided
Next steps
Copyright © 2022 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.